These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37070437)

  • 1. Recent Progress in Selective COX-2 Inhibitor Formulations and Therapeutic Applications - A Patent Review (2012-2022).
    Mittal R; Sharma S; Mittal A; Mittal A
    Mini Rev Med Chem; 2023; 23(22):2130-2141. PubMed ID: 37070437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.
    Lehmann FS; Beglinger C
    Curr Top Med Chem; 2005; 5(5):449-64. PubMed ID: 15974940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Druggable Prostanoid Pathway.
    Mazaleuskaya LL; Ricciotti E
    Adv Exp Med Biol; 2020; 1274():29-54. PubMed ID: 32894506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase isoforms and atherosclerosis.
    Belton O; Fitzgerald DJ
    Expert Rev Mol Med; 2003 Mar; 5(9):1-18. PubMed ID: 14987412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.
    Zarghi A; Arfaei S
    Iran J Pharm Res; 2011; 10(4):655-83. PubMed ID: 24250402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs for acute gout.
    van Durme CM; Wechalekar MD; Buchbinder R; Schlesinger N; van der Heijde D; Landewé RB
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010120. PubMed ID: 25225849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review].
    Mateos JL
    Drugs Today (Barc); 2010 Feb; 46 Suppl A():1-25. PubMed ID: 20224826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 and prostaglandins in articular tissues.
    Martel-Pelletier J; Pelletier JP; Fahmi H
    Semin Arthritis Rheum; 2003 Dec; 33(3):155-67. PubMed ID: 14671726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
    Rao P; Knaus EE
    J Pharm Pharm Sci; 2008 Sep; 11(2):81s-110s. PubMed ID: 19203472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspective on the cardiovascular effects of coxibs.
    Konstam MA; Weir MR
    Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?
    Savage R
    Drugs Aging; 2005; 22(3):185-200. PubMed ID: 15813652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs.
    Urban MK
    Orthopedics; 2000 Jul; 23(7 Suppl):S761-4. PubMed ID: 10914695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drugs for acute gout.
    van Durme CM; Wechalekar MD; Landewé RB; Pardo Pardo J; Cyril S; van der Heijde D; Buchbinder R
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010120. PubMed ID: 34882311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacology of non-steroidal anti-inflammatory drugs and ENT pathology].
    Devillier P
    Presse Med; 2001 Dec 22-29; 30(39-40 Pt 2):70-9. PubMed ID: 11819916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.